Mast cells infiltrates are common in eosinophilic esophagitis and still elevated in histological remission: A digital evaluation in children
- PMID: 40600368
- PMCID: PMC12408972
- DOI: 10.1002/jpn3.70137
Mast cells infiltrates are common in eosinophilic esophagitis and still elevated in histological remission: A digital evaluation in children
Abstract
Objectives: Eosinophilic esophagitis (EoE) is a type 2 inflammatory chronic allergic disease with several additional immune cell subsets being involved. The aim of this study was to assess the identification and quantification of mast cells (MC) infiltrates using an objective and examiner independent analysis via digital image analysis of digitized histochemically stained biopsies.
Methods: Biopsies were taken from the esophagus of 24 children and adolescents diagnosed with EoE and stained for MC and eosinophilic granulocytes using anti-CD117 and Congo red, respectively. Samples were digitized, eosinophilic granulocytes and MCs were quantified using the MIKAIA® image analysis software.
Results: At diagnosis MC infiltrations were regularly observed in active disease. MC numbers were 160 (cells/mm2) before therapy initiation and 33 (cells/mm2) in histological remission (<15 Eos/HPF). The number of mucosal MCs at the time of remission decreased less than that of eosinophilic granulocytes, regardless of the initiated therapy. Therefore, patients in histological remission with eosinophilic granulocytes showing on average 2,4 cells/mm2 still exhibited MC infiltrations (average 33 cells/mm2). Furthermore, male patients displayed higher numbers of eosinophilic granulocytes at time of diagnosis. With regard to the site of biopsy sampling, an accumulation of the MC count in the distal direction can be observed.
Conclusions: Mast cells are involved in EoE and persist after achieving histological remission. Both CD117 + MC and eosinophilic granulocytes can be quantified using MIKAIA® as a tool for objectifying the histological diagnosis of EoE.
Trial registration: Identification number: DRKS-ID 00014688; https://drks.de/search/de/trial/DRKS00014688.
Keywords: CD‐117; Congo Red; allergy; digital image analysis; pediatric.
© 2025 The Author(s). Journal of Pediatric Gastroenterology and Nutrition published by Wiley Periodicals LLC on behalf of European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
IgE-Mediated Food Sensitization, Management Strategies, and Quality of Life in Pediatric Eosinophilic Esophagitis: A Prospective Observational Study.Nutrients. 2025 Jun 11;17(12):1980. doi: 10.3390/nu17121980. Nutrients. 2025. PMID: 40573091 Free PMC article.
-
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.N Engl J Med. 2024 Jun 27;390(24):2239-2251. doi: 10.1056/NEJMoa2312282. N Engl J Med. 2024. PMID: 38924731 Clinical Trial.
-
Yield of esophageal biopsy patterns for the diagnosis of eosinophilic esophagitis.Gastrointest Endosc. 2025 Aug;102(2):194-201.e1. doi: 10.1016/j.gie.2025.01.018. Epub 2025 Jan 18. Gastrointest Endosc. 2025. PMID: 39832555
-
Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis.Gastroenterology. 2014 Jun;146(7):1639-48. doi: 10.1053/j.gastro.2014.02.006. Epub 2014 Feb 15. Gastroenterology. 2014. PMID: 24534634
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
References
-
- Oliva S, Dias JA, Rea F, et al. Characterization of eosinophilic esophagitis from the European Pediatric Eosinophilic Esophagitis Registry (pEEr) of ESPGHAN. J Pediatr Gastroenterol Nutr. 2022;75(3):325‐333. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical